pentetic acid has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Myint, ZW | 1 |
El Khouli, R | 1 |
Lemieux, B | 1 |
Yan, D | 1 |
St Clair, WH | 1 |
Liu, X | 1 |
Kunos, CA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Single Arm Phase II Study of Bone-Targeted Sn-117m-DTPA in Symptomatic Castration Resistant Prostate Cancer With Skeletal Metastases[NCT04616547] | Phase 2 | 1 participants (Actual) | Interventional | 2021-12-18 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for pentetic acid and Prostatic Neoplasms, Castration-Resistant
Article | Year |
---|---|
A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases.
Topics: Bone Neoplasms; Cancer Pain; Humans; Male; Pentetic Acid; Prospective Studies; Prostatic Neoplasms, | 2022 |